Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 27, 2019 Off

Acerus Provides Update On Avanafil Health Canada Submission

By BusinessWire

TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF) (“Acerus” or the “Company”) today announced that Health Canada has completed the initial screening…

June 27, 2019 Off

2019 Market Spotlight: Coronary Artery Disease – 365.9 Million Prevalent Cases Forecast by 2026 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Coronary Artery Disease” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers the…

June 27, 2019 Off

Advaxis Announces Increasing Focus on Neoantigen-Directed Immunotherapies and Closing of Its Phase 3 AIM2CERV Study

By BusinessWire

PRINCETON, N.J.–(BUSINESS WIRE)–Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today…

June 27, 2019 Off

SpringWorks Therapeutics Announces Global Clinical Collaboration with GlaxoSmithKline to Evaluate Nirogacestat in Combination with Belantamab Mafodotin in Patients with Relapsed or Refractory Multiple Myeloma

By BusinessWire

STAMFORD, Conn.–(BUSINESS WIRE)–SpringWorks Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases…

June 27, 2019 Off

ImmunoGen Announces Completion of Operational Review

By BusinessWire

Company Will Prioritize Continued Development of Mirvetuximab Soravtansine and a Select Portfolio of Earlier-Stage Candidates Cash Runway Extended Through Readout…

June 27, 2019 Off

Global Hepatitis B Market Spotlight 2019 – 10 Year Disease Prevalence Forecasts – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Hepatitis B” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers the Hepatitis…

June 27, 2019 Off

Takeda Selects Five New Partnerships for Annual Global Corporate Social Responsibility (CSR) Program

By BusinessWire

Takeda’s founding mission to serve patients, wherever they are, drives its increased commitments to disease prevention, capacity building, and access to healthcare in developing and emerging countries, in partnership with the global community.

MODAG in series A financing of €12 M to develop treatments for Parkinsonian Disorders
June 27, 2019 Off

MODAG in series A financing of €12 M to develop treatments for Parkinsonian Disorders

By BusinessWire

— Dr. Torsten Matthias appointed CEO, scientific founder Prof. Dr. Armin Giese joins as CSO —

— SERY technology in-licensed from Max-Planck Innovation GmbH to design next-generation candidate portfolio —

Emergex, IMCB in deal to make vaccine against most virulent enteroviruses
June 27, 2019 Off

Emergex, IMCB in deal to make vaccine against most virulent enteroviruses

By BusinessWire

Agreement targets the development of a cross-reactive vaccine to protect against the most virulent enteroviruses, including enterovirus 71 (EV71)

Regeneron, Sanofi’s Dupixent OK’d by FDA for combos to treat certain nasal  diseases
June 27, 2019 Off

Regeneron, Sanofi’s Dupixent OK’d by FDA for combos to treat certain nasal diseases

By Dino Mustafić

Regeneron Pharmaceuticals and Sanofi got the approval from the FDA for Dupixent for certain combinations to treat chronic rhinosinusitis with nasal polyposis (CRSwNP) in adults whose disease is not controlled.

Posts pagination

Previous 1 … 3,042 3,043 3,044 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine